Retractable Technologies, Inc. (NYSE:RVP) CEO Purchases $12,468.82 in Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw acquired 20,111 shares of the firm’s stock in a transaction that occurred on Tuesday, November 26th. The shares were purchased at an average price of $0.62 per share, with a total value of $12,468.82. Following the acquisition, the chief executive officer now owns 14,875,244 shares of the company’s stock, valued at approximately $9,222,651.28. This trade represents a 0.14 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Retractable Technologies Stock Performance

RVP stock opened at $0.63 on Wednesday. Retractable Technologies, Inc. has a 1-year low of $0.56 and a 1-year high of $1.34. The company has a current ratio of 8.57, a quick ratio of 5.92 and a debt-to-equity ratio of 0.01. The firm has a market cap of $18.84 million, a PE ratio of -1.16 and a beta of 1.98. The business’s 50-day moving average price is $0.71 and its two-hundred day moving average price is $0.92.

Hedge Funds Weigh In On Retractable Technologies

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC purchased a new stake in Retractable Technologies, Inc. (NYSE:RVP) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned approximately 0.12% of Retractable Technologies as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors and hedge funds own 7.58% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, StockNews.com began coverage on shares of Retractable Technologies in a research report on Wednesday, November 27th. They set a “hold” rating on the stock.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.